(Q44729128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ta-Chiang Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Gunnel Halldén

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Yaohe Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Arthi Anand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nick R Lemoine

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Jennelle Francis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lynda Hawkins

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

David Kirn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

412-424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Adenovirus proteins that subvert host defenses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Antineoplasic activity of parvoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Infection of Mouse Liver by Human Adenovirus Type 5

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Productive replication of human adenoviruses in mouse epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Role of early region 3 (E3) in pathogenesis of adenovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Conditionally replicating herpes vectors for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Modeling and analysis of a virus that replicates selectively in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

The role of adenovirus E4orf4 protein in viral replication and cell killing

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900199-0

7 January 2021

10.1016/S1525-0016(03)00199-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946314%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference